Details of the Drug

General Information of Drug (ID: DMTAX8B)

Drug Name
S-2150
Indication
Disease Entry ICD 11 Status REF
Angina pectoris BA40 Phase 2 [1]
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 98.11
Logarithm of the Partition Coefficient (xlogp) 0
Rotatable Bond Count (rotbonds) 0
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C3H6N4
IUPAC Name
5-methyl-1H-1,2,4-triazol-3-amine
Canonical SMILES
CC1=NC(=NN1)N
InChI
InChI=1S/C3H6N4/c1-2-5-3(4)7-6-2/h1H3,(H3,4,5,6,7)
InChIKey
FJRZOOICEHBAED-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
234610
CAS Number
4923-01-7
TTD ID
D01MPE

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Calcium channel unspecific (CaC) TT5HONZ NOUNIPROTAC Modulator [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Pharmacodynamics of S-2150, a simultaneous calcium-blocking and alpha1-inhibiting antihypertensive drug, in rats. J Pharm Pharmacol. 2000 Mar;52(3):273-80.